Liquidia Technologies, Inc. $LQDA Shares Sold by Significant Wealth Partners LLC

Significant Wealth Partners LLC lowered its position in shares of Liquidia Technologies, Inc. (NASDAQ:LQDA) by 21.9% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 11,240 shares of the company’s stock after selling 3,156 shares during the quarter. Significant Wealth Partners LLC’s holdings in Liquidia Technologies were worth $140,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Goldman Sachs Group Inc. lifted its holdings in shares of Liquidia Technologies by 10.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock valued at $12,703,000 after buying an additional 82,955 shares during the period. Boothbay Fund Management LLC lifted its holdings in shares of Liquidia Technologies by 18.7% in the 1st quarter. Boothbay Fund Management LLC now owns 662,873 shares of the company’s stock valued at $9,777,000 after buying an additional 104,215 shares during the period. Adage Capital Partners GP L.L.C. lifted its holdings in shares of Liquidia Technologies by 446.7% in the 1st quarter. Adage Capital Partners GP L.L.C. now owns 461,248 shares of the company’s stock valued at $6,803,000 after buying an additional 376,872 shares during the period. Two Sigma Investments LP lifted its holdings in shares of Liquidia Technologies by 21.4% in the 4th quarter. Two Sigma Investments LP now owns 381,237 shares of the company’s stock valued at $4,483,000 after buying an additional 67,134 shares during the period. Finally, Wellington Management Group LLP lifted its holdings in shares of Liquidia Technologies by 9.0% in the 1st quarter. Wellington Management Group LLP now owns 196,226 shares of the company’s stock valued at $2,894,000 after buying an additional 16,227 shares during the period. Institutional investors and hedge funds own 64.54% of the company’s stock.

Insider Activity at Liquidia Technologies

In other Liquidia Technologies news, insider Rajeev Saggar sold 20,000 shares of the business’s stock in a transaction that occurred on Thursday, August 28th. The stock was sold at an average price of $27.85, for a total transaction of $557,000.00. Following the completion of the sale, the insider directly owned 249,727 shares in the company, valued at approximately $6,954,896.95. The trade was a 7.41% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Raman Singh sold 45,524 shares of the business’s stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $25.81, for a total value of $1,174,974.44. Following the sale, the director owned 31,255 shares of the company’s stock, valued at approximately $806,691.55. This trade represents a 59.29% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 881,097 shares of company stock worth $23,689,864 in the last quarter. Corporate insiders own 26.50% of the company’s stock.

Liquidia Technologies Price Performance

Shares of Liquidia Technologies stock opened at $21.94 on Thursday. The company has a quick ratio of 2.41, a current ratio of 2.49 and a debt-to-equity ratio of 9.84. Liquidia Technologies, Inc. has a twelve month low of $9.71 and a twelve month high of $29.94. The business has a 50-day moving average price of $23.60 and a 200 day moving average price of $17.66. The firm has a market cap of $1.89 billion, a PE ratio of -12.91 and a beta of 0.22.

Liquidia Technologies (NASDAQ:LQDA) last announced its quarterly earnings results on Tuesday, August 12th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.43) by ($0.06). Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The business had revenue of $8.84 million during the quarter, compared to analysts’ expectations of $3.90 million. The business’s revenue was up 141.5% on a year-over-year basis. Sell-side analysts predict that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on LQDA. Wells Fargo & Company boosted their price objective on Liquidia Technologies from $25.00 to $31.00 and gave the company an “overweight” rating in a report on Wednesday, August 13th. Jefferies Financial Group began coverage on Liquidia Technologies in a report on Friday, August 15th. They issued a “buy” rating and a $43.00 price objective for the company. Needham & Company LLC boosted their price objective on Liquidia Technologies from $32.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, August 12th. Scotiabank lifted their price target on Liquidia Technologies from $36.00 to $37.00 and gave the company a “sector outperform” rating in a research note on Wednesday, May 28th. Finally, HC Wainwright lifted their price target on Liquidia Technologies from $29.00 to $35.00 and gave the company a “buy” rating in a research note on Wednesday, May 28th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $32.11.

Liquidia Technologies Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).